Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Asha M. Das, Mario Pescatori, Cindy E. Vermeulen, Joost A. P. Rens, Ann L. B. Seynhaeve, Gerben A. Koning, Alexander M. M. Eggermont & Timo L. M. ten Hagen. (2016) Melanomas prevent endothelial cell death under restrictive culture conditions by signaling through AKT and p38 MAPK/ ERK-1/2 cascades. OncoImmunology 5:10.
Read now
Read now
Kriti Mittal, Henry Koon, Paul Elson, Pierre Triozzi, Afshin Dowlati, Helen Chen, Ernest C Borden & Brian I Rini. (2014) Dual VEGF/VEGFR inhibition in advanced solid malignancies. Cancer Biology & Therapy 15:8, pages 975-981.
Read now
Read now
Articles from other publishers (18)
Hailong He, Christine Schönmann, Mathias Schwarz, Benedikt Hindelang, Andrei Berezhnoi, Susanne Annette Steimle-Grauer, Ulf Darsow, Juan Aguirre & Vasilis Ntziachristos. (2022) Fast raster-scan optoacoustic mesoscopy enables assessment of human melanoma microvasculature in vivo. Nature Communications 13:1.
Crossref
Crossref
Dehai Xian, Jing Song, Lingyu Yang, Xia Xiong, Rui Lai & Jianqiao Zhong. (2019) Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses. Oxidative Medicine and Cellular Longevity 2019, pages 1-14.
Crossref
Crossref
Xiaocheng Zhou, Tinglin Yan, Chunming Huang, Zhi Xu, Lin Wang, Erhui Jiang, Hui Wang, Yang Chen, Ke Liu, Zhe Shao & Zhengjun Shang. (2018) Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Asha M. Das, Senada Koljenović, Charlotte M.C. Oude Ophuis, Thom van der Klok, Boris Galjart, Alex L. Nigg, Wiggert A. van Cappellen, Vincent Noordhoek Hegt, Winand N.M. Dinjens, Peggy N. Atmodimedjo, Cindy E. Vermeulen, Cornelis Verhoef, Alexander M.M. Eggermont & Timo L.M. ten Hagen. (2016) Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma. European Journal of Cancer 53, pages 135-143.
Crossref
Crossref
Trude G. Simonsen, Jon-Vidar Gaustad & Einar K. Rofstad. (2015) Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Crossref
David S. Hong, Razelle Kurzrock, Jennifer J. Wheler, Aung Naing, Gerald S. Falchook, Siqing Fu, Kevin B. Kim, Michael A. Davies, Ly M. Nguyen, Goldy C. George, Lucy Xu, Robert Shumaker, Min Ren, Jennifer Mink, Cynthia Bedell, Corina Andresen, Pallavi Sachdev, James P. O'Brien & John Nemunaitis. (2015) Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma. Clinical Cancer Research 21:21, pages 4801-4810.
Crossref
Crossref
Onat Kadioglu, Ean Jeong Seo & Thomas Efferth. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
823
850
.
Raquel Muñoz, Yolanda Arias, José Miguel Ferreras, Pilar Jiménez, Carmen Langa, María Angeles Rojo, Manuel José Gayoso, Damián Córdoba-Díaz, Carmelo Bernabéu & Tomás Girbés. (2012) In vitro and in vivo effects of an anti-mouse endoglin (CD105)–immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours. Cancer Immunology, Immunotherapy 62:3, pages 541-551.
Crossref
Crossref
R.M. Martí, A. Sorolla & A. Yeramian. (2012) New Therapeutic Targets in Melanoma. Actas Dermo-Sifiliográficas (English Edition) 103:7, pages 579-590.
Crossref
Crossref
R.M. Martí, A. Sorolla & A. Yeramian. (2012) Nuevas dianas terapéuticas en el melanoma. Actas Dermo-Sifiliográficas 103:7, pages 579-590.
Crossref
Crossref
D S Boss, H Glen, J H Beijnen, M Keesen, R Morrison, B Tait, W Copalu, A Mazur, J Wanders, J P O'Brien, J H M Schellens & T R J Evans. (2012) A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours. British Journal of Cancer 106:10, pages 1598-1604.
Crossref
Crossref
Gérald E. Piérard, Claudine Piérard-Franchimont & Philippe Delvenne. (2012) Malignant Melanoma and Its Stromal Nonimmune Microecosystem. Journal of Oncology 2012, pages 1-8.
Crossref
Crossref
Daniel S. Chen. 2012. Targeted Therapeutics in Melanoma. Targeted Therapeutics in Melanoma
155
184
.
Michael Campoli, Scott Freeman, David G. Brodland & John Zitelli. 2012. Mohs Micrographic Surgery. Mohs Micrographic Surgery
211
223
.
Iris Helfrich & Dirk Schadendorf. (2011) Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: One step forward for overcoming anti-angiogenic drug resistance?. Molecular Oncology 5:2, pages 137-149.
Crossref
Crossref
PASCALE QUATRESOOZ, MARIE-ANNICK REGINSTER & GÉRALD E. PIÉRARD. (2011) ‘Malignant melanoma microecosystem’: Immunohistopathological insights into the stromal cell phenotype. Experimental and Therapeutic Medicine 2:3, pages 379-384.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Supportive & Palliative Care 4:4, pages 293-304.
Crossref
Crossref
P.G. CorrieB. Basu & K. Ahmad Zaki. (2010) Targeting angiogenesis in melanoma: prospects for the future. Therapeutic Advances in Medical Oncology 2:6, pages 367-380.
Crossref
Crossref